Skip to main content
Premium Trial:

Request an Annual Quote

Bruker CEO to Provide Details of Reorganization at Upcoming Investor Conference

This article has been updated from an earlier version to include details from spokesman.


NEW YORK, Sept. 10 (GenomeWeb News) - Frank Laukien, president and CEO of Bruker BioSciences, is expected to provide details of his company's recently announced reorganization at next week's Bear Stearns healthcare conference, according to a company spokesman.

Earlier today, Bruker said it has laid off around 60 employees worldwide as it tries to rein in "creeping" expenses. The company also said it has "reorganized various production, research and development, sales and administration functions" to help save additional money. The move is expected to save the company $6 million in the fourth quarter of this year, and for the whole of 2005.


Bruker "had some bottom-line set-backs and expense creep recently, which we intend to counter with this additional cost-cutting program that has affected all of our operating companies and geographies," Laukien said in a statement.


Laukien is scheduled to speak at Eastern Standard Time on Monday, Sept. 13. The presentation will be webcast on  Bruker's website.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.